Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.02 (+9.52%)
As of: Sep 30, 2026 · 10:24 AM EDT

Theriva Biologics (TOVX) Total Debt (2022 - 2026)

Updated

Theriva Biologics' Total Debt came in at $1.65 million for Q2 2026, down 2.4% from $1.7 million a year earlier and down 0.4% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2025, Theriva Biologics' Total Debt was $1.73 million.

  • Total Debt carries a three-year compound annual growth rate of 83.9% (FY2022 to FY2025).
  • Going back by year, Total Debt was $153,000 in FY2024 (-32.0%), $225,000 in FY2023 (-19.1%) and $278,000 in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Total Debt since Q1 2025.
  • Year-over-year, Total Debt increased in four of the last seven quarters, with growth averaging 356.4%.
  • The fastest year-over-year change in Total Debt over five years came in Q2 2025 (growth of 993.5%), and the weakest in Q4 2024 (a decline of 32.0%).
  • Business Quant data shows TOVX's Total Debt at $1.66 million (Q1 2026), $1.73 million (Q4 2025) and $1.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Theriva Biologics 10.10 Mn 10.10 Mn - 1.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.65 Mn
Mar 31, 2026 1.66 Mn
Dec 31, 2025 1.73 Mn
Sep 30, 2025 1.71 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 153,000.00
Sep 30, 2024 163,000.00
Jun 30, 2024 155,000.00
Mar 31, 2024 221,000.00
Dec 31, 2023 225,000.00
Sep 30, 2023 215,000.00
Jun 30, 2023 220,000.00
Mar 31, 2023 226,000.00
Dec 31, 2022 278,000.00
Sep 30, 2022 254,000.00
Jun 30, 2022 272,000.00
Mar 31, 2022 297,000.00
API Access

Theriva Biologics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=TOVX&period=max&api_key=YOUR_API_KEY